Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...
FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted ...
GlobalData on MSN
FDA clears Cepheid’s Xpert GI Panel for pathogen detection
The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.
Background IBD is characterised by recurrent flares, but evidence on whether modifiable dietary factors influence flare risk ...
Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback